Neuroinflammation in Lyme Disease
Brain fog can persist despite normal testing
Inflammation may affect memory and cognition
Neuroinflammation may help explain persistent symptoms
Lyme disease brain fog may be one of the most frustrating symptoms patients face. Problems with memory, concentration, slowed thinking, and cognitive fatigue may persist even when testing appears normal.
Neuroinflammation in Lyme disease may help explain why symptoms such as brain fog, fatigue, slowed thinking, and memory problems continue after infection.
Many patients describe difficulty concentrating, reduced mental clarity, and cognitive fatigue that interfere with work, school, and daily functioning.
A 2025 systematic review and meta-analysis found that neurologic complications were reported in approximately 18% of patients with Lyme disease. Cognitive and emotional disorders, including memory problems, poor concentration, and word-finding difficulties, were among the neurologic manifestations identified across the included studies. The authors also noted substantial differences among the studies and evidence of possible publication bias.
These symptoms may reflect inflammatory and functional changes affecting the brain and nervous system rather than structural injury alone. Changes in immune signaling, glial activity, cerebral metabolism, and brain function may occur without producing abnormalities visible on routine MRI studies.
Neuroinflammation is closely linked to immune dysregulation in Lyme disease, where altered immune signaling may continue affecting neurologic function.
For a broader framework explaining persistent symptoms, see Persistent Lyme Disease Overview.
These processes may fit within broader persistent Lyme disease mechanisms contributing to ongoing neurologic symptoms.
What is neuroinflammation?
Neuroinflammation refers to activation of immune pathways within the brain and central nervous system.
This process involves immune cells such as microglia and astrocytes responding to infection, inflammation, stress, or immune activation.
Microglia are resident immune cells within the central nervous system. They help recognize infection, remove damaged material, coordinate inflammatory responses, and support tissue repair.
Microglial activation can be protective during an infection. However, prolonged or dysregulated activation may alter communication among neurons and other supporting brain cells.
Neuroinflammation also involves inflammatory signaling molecules known as cytokines and chemokines. These immune messengers help coordinate the response to infection but may affect neurologic function when inflammatory signaling becomes prolonged or poorly regulated.
A laboratory study using primary human microglial cells found that exposure to Borrelia burgdorferi increased the expression and release of inflammatory mediators, including IL-6, IL-8, CXCL1, and CXCL10. The microglia also increased expression of receptors and genes involved in recognizing and responding to bacterial material.
These findings provide biologic evidence that Borrelia burgdorferi can activate human microglia and inflammatory signaling under laboratory conditions. They do not establish that bacterial debris persists in the human brain after treatment or that it causes chronic neuroinflammation in patients.
In Lyme disease, inflammatory signaling may affect how the brain processes information. However, the precise relationship between immune activation, neuroinflammation, and persistent cognitive symptoms remains under investigation.
How neuroinflammation contributes to Lyme disease brain fog
Inflammation within the nervous system may interfere with communication between neural networks involved in attention, memory, language, and processing speed.
Patients may experience:
- Brain fog
- Difficulty concentrating
- Slowed thinking
- Word-finding problems
- Mental fatigue
- Memory difficulties
These symptoms may be subtle but can significantly impair work, school, communication, and daily functioning.
For a symptom-focused overview, see Brain Fog and Lyme Disease.
Cognitive symptoms are commonly reported in Lyme disease and among patients with persistent post-treatment symptoms. The 2025 systematic review identified memory impairment, concentration difficulties, word-finding problems, fatigue, sleep disturbance, and other neurologic symptoms across the included studies.
In a small PET imaging study, investigators found evidence of increased glial activation in patients with persistent post-treatment Lyme disease symptoms. This finding supports the hypothesis that neuroinflammation may contribute to cognitive dysfunction in at least some patients.
Other imaging studies have reported altered cerebral metabolism and white matter abnormalities in selected patients. These findings do not establish that every patient with brain fog has measurable neuroinflammation, but they provide biologic evidence that persistent cognitive symptoms may occur even when routine structural testing is unrevealing.
“`html
Can Lyme disease cause memory problems?
Memory problems are frequently reported in Lyme disease and may reflect impaired processing speed, reduced attention, fatigue, sleep disruption, autonomic dysfunction, or inflammatory effects on cognitive networks.
Patients often describe forgetting names, misplacing objects, losing words during conversation, or struggling with multitasking.
These complaints do not always represent loss of stored memories. In many patients, the primary difficulty involves concentrating, efficiently processing new information, or retrieving information when mentally fatigued.
Some patients notice that memory problems gradually improve as attention, sleep quality, fatigue, autonomic function, and overall neurologic health improve.
Neuroinflammation and autonomic dysfunction
Neuroinflammation may also affect autonomic regulation controlling blood flow, heart rate, digestion, temperature regulation, and energy balance.
Disruption in these systems may reduce cerebral blood flow or make it more difficult for the nervous system to maintain cognitive performance during standing, physical activity, or prolonged mental effort.
This overlap helps explain connections between neuroinflammation and autonomic dysfunction in Lyme disease.
Why symptoms fluctuate
Neuroinflammation and neuroimmune signaling are dynamic, meaning symptoms may change over time.
- Periods of mental clarity followed by brain fog
- Worsening with stress or exertion
- Fluctuating memory problems
- Temporary improvement followed by relapse
This variability may reflect changing immune activity, sleep quality, autonomic regulation, physical exertion, medication effects, and nervous system signaling rather than permanent neurologic injury.
Fatigue frequently overlaps with these mechanisms. Learn more about Lyme disease fatigue.
Can neuroinflammation improve?
Neuroinflammation may improve over time as immune activity stabilizes, although recovery varies considerably among individuals.
As infection is treated and contributing factors such as sleep disturbance, autonomic dysfunction, pain, mood disorders, and physical deconditioning improve, many patients experience gradual improvement in cognitive symptoms.
Recovery often occurs over weeks or months and is not always linear.
Persistent or worsening cognitive symptoms should be evaluated rather than automatically attributed to Lyme disease. Other neurologic, metabolic, sleep-related, psychiatric, medication-related, or systemic conditions may also contribute.
Understanding the questions patients most commonly ask about brain fog and neuroinflammation may help place these symptoms into clinical context.
Frequently Asked Questions
Does Lyme disease cause brain fog?
Brain fog is commonly reported by patients with Lyme disease and persistent post-treatment symptoms. Neuroinflammation, autonomic dysfunction, fatigue, sleep disruption, and altered immune signaling may all contribute.
Can Lyme disease cause memory loss?
Patients frequently report memory problems, slowed recall, and difficulty processing information. These symptoms often reflect impaired attention, processing speed, or information retrieval rather than permanent loss of stored memories.
What are symptoms of neuroinflammation?
Possible symptoms associated with neuroinflammation include brain fog, slowed thinking, mental fatigue, difficulty concentrating, memory problems, headache, sleep disturbance, and increased sensitivity to physical or cognitive exertion. These symptoms are not specific to Lyme disease and may have many causes.
What causes neuroinflammation in Lyme disease?
Infection-related immune activation, cytokines, chemokines, glial activation, and broader neuroimmune dysregulation may contribute. The mechanisms responsible for persistent cognitive symptoms remain incompletely understood.
Can neuroinflammation occur with normal MRI results?
Yes. Routine MRI primarily detects structural abnormalities. Functional changes involving immune signaling, glial activation, cerebral metabolism, or nervous system regulation may occur without visible abnormalities on conventional MRI.
Clinical Takeaway
Brain fog, memory problems, cognitive fatigue, and slowed thinking may reflect a combination of neuroinflammation, immune dysregulation, autonomic dysfunction, sleep disturbance, and other contributing factors rather than structural brain injury alone.
Experimental studies demonstrate that Borrelia burgdorferi can activate human microglia under laboratory conditions, while PET imaging studies have shown evidence of glial activation in some patients with persistent post-treatment Lyme disease symptoms. Together, these findings provide biologic support for the hypothesis that neuroinflammation may contribute to cognitive symptoms, although additional clinical research is needed to clarify the underlying mechanisms.
Related Articles
Explore related neurologic symptoms, diagnostic questions, and recovery pathways:
Neurologic Lyme Disease
Brain Fog and Lyme Disease
Autonomic Dysfunction in Lyme Disease
Recovery From Lyme Disease
Post-treatment Lyme Disease Syndrome
References
- Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003.
- Coughlin JM, Yang T, Rebman AW, et al. Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using PET. J Neuroinflammation. 2018;15(1):346.
- Newberg AB, Hassan A, Alavi A. Cerebral metabolic changes associated with Lyme disease. Nucl Med Commun. 2002;23(8):773-777.
- Roos KL. Neurologic complications of Lyme disease. Continuum (Minneap Minn). 2021;27(4):1040-1050.
- Bushi G, Balaraman AK, Gaidhane S, et al. Lyme disease associated neurological and musculoskeletal symptoms: a systematic review and meta-analysis. Brain Behav Immun Health. 2025;43:100931.
- Greenmyer JR, Gaultney RA, Brissette CA, Watt JA. Primary human microglia are phagocytically active and respond to Borrelia burgdorferi with upregulation of chemokines and cytokines. Front Microbiol. 2018;9:811.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
